STAT+: Anthropic releases Claude Science, a product aimed at researchers, the pharma industry

STAT PlusBiotech Anthropic releases Claude Science, a product aimed at researchers, the pharma industry The AI giant is seeking to fundamentally upend the life sciences Manage alerts for this article Email this article Share this article By Matthew Herper and Brittany TrangJune 30, 2026 Matthew Herper[email protected]Matthew Herper covers medical innovation — both its promise and its perils.Brittany Trang[email protected]Brittany Trang, Ph.D., covers AI in health and medicine: Does it actually work? Who benefits, or might be harmed? She writes the weekly AI Prognosis newsletter. Follow her on Threads, Mastodon, and Bluesky. You can reach Brittany on Signal at btrang.01. SAN FRANCISCO — Anthropic, the artificial intelligence firm, on Tuesday announced the availability of Claude Science, an application that optimizes the company’s large language model for use in scientific laboratories and, especially, within the research operations of pharmaceutical companies. At a launch event here, Anthropic CEO Dario Amodei said that until now, humans have wrestled with the complexity of biology only with their minds. While biology is not as simple or clean as code, he still thinks it can be just as powerful in this domain.Advertisement “It’s going to be a general purpose technology that helps us to make sense of that complexity, in its full complexity, better.” But, he admitted, “We don’t know for sure if that’s going to work out. But I think we’re seeing signs that we’re seeing the beginnings of it.” STAT+ Exclusive Story Already have an account? Log in This article is exclusive to STAT+ subscribers Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+. Already have an account? Log in Monthly $39 Totals $468 per year $39/month Get Started Totals $468 per year Starter $30 for 3 months, then $399/year $30 for 3 months Get Started Then $399/year Annual $399 Save 15% $399/year Get Started Save 15% 11+ Users Custom Savings start at 25%! Request A Quote Request A Quote Savings start at 25%! 2-10 Users $300 Annually per user $300/year Get Started $300 Annually per user View All Plans To read the rest of this story subscribe to STAT+. Subscribe Log In Artificial intelligence, biotechnology, drug development, Pharmaceuticals, STAT+ Submit a correction requestReprints Matthew Herper Senior Writer, Medicine, Editorial Director of Events Matthew Herper covers medical innovation — both its promise and its perils. Brittany Trang Health Tech Reporter Brittany Trang, Ph.D., covers AI in health and medicine: Does it actually work? Who benefits, or might be harmed? She writes the weekly AI Prognosis newsletter. Follow her on Threads, Mastodon, and Bluesky. You can reach Brittany on Signal at btrang.01. STAT+ Newsletter A hitchhiker's guide to the health care AI galaxy Recommended Biotech June 30, 2026 STAT Plus: AI company Anthropic announces it will begin developing drugs of its own The Readout June 30, 2026 STAT Plus: Investors double down on Bain-backed startup Advertisement Health Tech Newsletter June 30, 2026 STAT Plus: FDA digital leader hints at coming AI policy updates Biotech June 30, 2026 STAT Plus: Abivax seeks to ease safety concerns with new data, boosting shares Exclusive June 29, 2026 STAT Plus: FDA’s top gene therapy regulator is leaving his role Subscriber Picks